DOI: 10.36347/sjmcr.2024.v12i04.037

Pages: 537-538

Lamotrigine is a second-generation anticonvulsant approved for the treatment of epilepsy. Like other antiepileptics, lamotrigine is also used off-label in bipolar disorders as a mood stabiliser. We describe the case of a patient suffering from bipolar disorder type 2 who developed ocular toxicity following the use of lamotrigine in the management of his mental illness. The vast majority of these visual side effects are non-serious, rare, of mild to moderate intensity. And they appear to be reversible once treatment is stopped.